Eagle Rock Investment Company LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 24.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,206 shares of the company's stock after purchasing an additional 6,960 shares during the period. HCA Healthcare comprises 1.8% of Eagle Rock Investment Company LLC's investment portfolio, making the stock its 15th largest position. Eagle Rock Investment Company LLC's holdings in HCA Healthcare were worth $10,567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare during the 2nd quarter valued at $33,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the third quarter worth about $39,000. Canoe Financial LP bought a new position in HCA Healthcare during the 3rd quarter valued at approximately $41,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare during the third quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare in the third quarter worth $44,000. Hedge funds and other institutional investors own 62.73% of the company's stock.
Several brokerages have commented on HCA. Wells Fargo & Company lowered shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and decreased their price objective for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Raymond James downgraded HCA Healthcare from an "outperform" rating to a "market perform" rating in a report on Friday, November 22nd. Finally, TD Cowen decreased their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $385.27.
Get Our Latest Research Report on HCA
Shares of NYSE:HCA opened at $309.26 on Friday. HCA Healthcare, Inc. has a 1 year low of $276.50 and a 1 year high of $417.14. The stock's fifty day moving average price is $318.49 and its 200-day moving average price is $353.11. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company has a market cap of $78.34 billion, a P/E ratio of 13.89, a PEG ratio of 1.03 and a beta of 1.64.
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. HCA Healthcare's dividend payout ratio (DPR) is 11.85%.
In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company's stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company's stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.